MetaCap

Trulieve Cannabis Corp. Subordinate Voting Shares (TRLV)

NYSE: TRLVHealth Care Medicinal Chemicals and Botanical Products USD

8.68-0.67 (-7.17%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

TRLV stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$2.31
52-week range
5.00 – 13.28
Day range
8.68 – 9.42
Volume / Avg
1.71M / 1.85M
Beta
—

52-week range

$5.00$13.28

TRLV stock today

Shares of Trulieve Cannabis Subordinate Voting Shares (TRLV) finished lower on Nov 20 at $8.68, a drop of 7.17% or $0.67 per share, versus the S&P 500's 3.70% decline. At this level, TRLV sits in the middle of its 52-week range of $5.00 to $13.28: 34.6% below the high, set on Jun 9, 2026 and 73.6% above the low. TRLV is down 0.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 61.3%.

Trulieve Cannabis Subordinate Voting Shares has posted a net loss over the last twelve months (EPS of -$2.31), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Trulieve Cannabis Subordinate Voting Shares

Company profile

Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery.

Industry
Medicinal Chemicals and Botanical Products
CEO
Ms. Kimberly Rivers J.D.
Headquarters
Tallahassee, FL
Employees
5,000

Financial highlights

Full financials

In fiscal 2025, Trulieve Cannabis Subordinate Voting Shares generated $1.18 billion in revenue, down 0.4% from fiscal 2024, its first annual decline since 2023. Trulieve Cannabis Subordinate Voting Shares reported a net loss of $122.2 million, compared with a loss of $160.6 million a year earlier. Gross margin was 60.2% (down from 60.3%) and operating margin 12.1%.

Trulieve Cannabis Subordinate Voting Shares annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$1.18B$1.19B$1.13B$1.22B$931.93M
Growth-0.45%+5.07%-7.31%+30.72%+78.69%
Net income$-122.25M$-160.58M$-533.14M$-252.73M$17.45M
EPS (diluted)$-0.58$-0.79$-2.28$-0.95$0.21

Analyst forecast

Forecast

Consensus (7 analysts)

strong_buy

Avg. price target

$18.32+111.06%

  • Strong buy 1
  • Buy 6
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $15.00High $22.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 5, 2026
EPS actual vs est.
$0.00 vs $0.09
Surprise
-100.00%

TRLV news

All TRLV news

Trulieve Cannabis Subordinate Voting Shares peers

Health Care sector
TRLV peer companies
CompanyPrice% ChgMarket capCompare
CRONCronos Group Inc.3.04-1.30%$1.11Bvs TRLV
RGCRegencell Bioscience Holdings Limited4.18-4.13%$2.07Bvs TRLV
OBIOOrchestra BioMed Holdings Inc.6.58-6.00%$517.88Mvs TRLV
SNDLSNDL Inc.1.17-5.65%$285.20Mvs TRLV
TLRYTilray Brands Inc.1.89-8.70%$279.32Mvs TRLV
ACBAurora Cannabis Inc.4.16-2.35%$273.50Mvs TRLV
USNAUSANA Health Sciences Inc.12.94-1.67%$239.24Mvs TRLV
MDWDMediWound Ltd.13.59+0.37%$195.56Mvs TRLV

Indexes, lists and sector

Trulieve Cannabis Subordinate Voting Shares stock FAQ

What is Trulieve Cannabis Subordinate Voting Shares's stock price today?

TRLV last traded at $8.68 as of Nov 20, 4:00 PM EST, down 7.17% on the day. Prices are delayed at least 15 minutes.

Who is Trulieve Cannabis Subordinate Voting Shares's CEO?

Ms. Kimberly Rivers J.D. is the chief executive officer of Trulieve Cannabis Corp. Subordinate Voting Shares, which has about 5,000 employees.

What is the TRLV 52-week high?

The 52-week high for TRLV is $13.28 and the 52-week low is $5.00. The stock is currently 34.6% below its high.

Compare TRLV